Drug Price Trends for CODEINE SULFATE

Average Pharmacy Cost for CODEINE SULFATE

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
CODEINE SULFATE 15 MG TABLET	00054-0243-24	0.66539	EACH	2024-12-18
CODEINE SULFATE 30 MG TABLET	00054-0244-25	0.63478	EACH	2024-12-18
CODEINE SULFATE 30 MG TABLET	00054-0244-24	0.63478	EACH	2024-12-18
CODEINE SULFATE 60 MG TABLET	00054-0245-25	1.04692	EACH	2024-12-18
CODEINE SULFATE 30 MG TABLET	00527-1698-01	0.63478	EACH	2024-12-18
CODEINE SULFATE 15 MG TABLET	00054-0243-24	0.67536	EACH	2024-11-20

CODEINE SULFATE Market Analysis and Financial Projection

Codeine Sulfate Market Analysis and Price Projections

Overview of Codeine Sulfate

Codeine sulfate is an opioid medication widely used for its analgesic, antitussive, and antidiarrheal properties. It is a key component in both over-the-counter and prescription medications, particularly for pain management and cough suppression.

Market Dynamics

Market Size and Growth

The codeine market, which includes codeine sulfate, has been growing steadily. As of 2024, the codeine market was valued at USD 4.11 billion and is expected to grow at a Compound Annual Growth Rate (CAGR) of 4.65%, reaching USD 5.40 billion by 2030[4].

Market Drivers

• Increasing Prevalence of Chronic Pain and Cough Conditions: The rising incidence of respiratory and pain-related ailments, especially among the elderly population, drives the demand for codeine sulfate[4].
• Structured Regulatory Frameworks: Regulatory frameworks aimed at ensuring the safe distribution of controlled substances support the market growth by providing a clear and stable environment for manufacturers and distributors[4].

Market Restraints

• High Costs of Production and Commercialization: The high costs associated with the production and commercialization of codeine sulfate can act as a barrier to market growth[4].
• Strict Regulatory Controls: Stringent regulations to prevent misuse and addiction can limit the market expansion[4].

Market Opportunities

• Collaborative Developments: Collaborations between pharmaceutical companies and research institutions can lead to innovative and efficient uses of codeine sulfate, driving market growth[4].
• Advancements in Controlled-Release Formulations: The development of controlled-release formulations enhances patient compliance and can expand the market[4].

Market Challenges

• Prevalence of Counterfeit Products: The presence of counterfeit products with codeine poses a significant challenge to the legitimate market[4].

Price Analysis

Current Pricing

The cost of codeine sulfate varies based on the dosage and formulation. For example:

• Codeine Sulfate 15 mg Oral Tablet: Prices start from around $82.84 for a supply of 100 tablets, with a per-unit cost of approximately $0.83[2].
• Codeine Sulfate 30 mg Oral Tablet: Prices range from $88.57 to $167.98 for a supply of 100 tablets, with a per-unit cost between $0.89 and $1.68[2].
• Codeine Sulfate 60 mg Oral Tablet: Prices start from around $154.40 for a supply of 100 tablets, with a per-unit cost of approximately $1.54[2].

Price Projections

Given the market growth and increasing demand, prices are likely to remain stable or see a moderate increase. Here are some key factors influencing price projections:

• Supply and Demand Balance: The balance between supply and demand will play a crucial role in price stability. Increasing demand due to rising chronic pain and cough conditions is expected to be met by expanded production, which could keep prices relatively stable[4].
• Regulatory Environment: Strict regulations may impact the availability and thus the pricing of codeine sulfate. However, structured regulatory frameworks are expected to ensure a stable market environment[4].
• Innovative Formulations: The development of new and efficient formulations, such as controlled-release formulations, may lead to slightly higher prices due to the advanced technology involved[4].

Market Segmentation

Formulation

Codeine sulfate is available in various formulations, including:

• Tablets: Available in different strengths such as 15 mg, 30 mg, and 60 mg[2][5].
• Syrups: Often preferred due to higher patient compliance, especially in pediatric and geriatric populations[4].
• Capsules: Another common formulation, though less preferred compared to syrups and tablets[4].

Application

The primary applications of codeine sulfate include:

• Cough Suppression: Codeine is widely recognized for its antitussive properties, making it a key ingredient in cough medications[4][5].
• Diarrhea Suppression: It is also used to treat diarrhea, particularly in cases where other treatments are ineffective[4][5].
• Pain Management: Codeine sulfate is used for managing mild to moderate pain, often in combination with other analgesics like acetaminophen or ASA[4][5].

Distribution Channel

Codeine sulfate is distributed through various channels:

• Offline: Hospitals, clinics, and pharmacies are the primary offline distribution channels[4].
• Online: Online pharmacies and e-commerce platforms also play a significant role, especially for patients with mobility issues or those living in remote areas[4].

Regional Analysis

Global Market

The global opioid market, which includes codeine sulfate, is anticipated to grow at a CAGR of 1.4% from 2023 to 2030, reaching USD 25.3 billion by 2030. North America currently holds the largest share, but the Asia Pacific region is expected to grow at the fastest CAGR of 5.5% during the forecast period due to government initiatives to control opioid misuse and increase the prescription rate for high-quality opioids[3].

Key Market Players

Some of the leading vendors in the codeine market include:

• Abbott Laboratories
• Accord Healthcare by Intas Pharmaceuticals
• Advik Pharma
• AstraEureka Pharmaceuticals
• Bristol Laboratories Limited
• Crescent Pharma Limited
• Johnson Matthey Plc
• Noramco, Inc.
• Omnica Laboratories
• Pfizer Inc.
• Professional Compounding Centers of America, Inc.
• SANOFI WINTHROP INDUSTRIE
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.[4].

Regulatory Environment

The codeine sulfate market is heavily regulated due to its potential for misuse and addiction. Regulatory bodies such as the FDA in the U.S. and similar agencies in other countries play a crucial role in ensuring the safe distribution and use of codeine sulfate. For instance, measures such as warning labels about the risk of opioid overdose are being implemented to increase awareness and safety[3][4].

Key Takeaways

• Market Growth: The codeine sulfate market is expected to grow at a CAGR of 4.65% until 2030.
• Price Stability: Prices are likely to remain stable or see a moderate increase due to balanced supply and demand.
• Regulatory Impact: Strict regulations will continue to shape the market, ensuring safe distribution and use.
• Innovative Formulations: Controlled-release formulations are expected to drive market growth and enhance patient compliance.
• Regional Growth: The Asia Pacific region is anticipated to grow at the fastest CAGR due to government initiatives.

FAQs

What are the primary applications of codeine sulfate?

Codeine sulfate is primarily used for cough suppression, diarrhea suppression, and pain management.

How is the codeine sulfate market expected to grow?

The codeine sulfate market is expected to grow at a CAGR of 4.65% until 2030, reaching USD 5.40 billion.

What are the key factors driving the codeine sulfate market?

Key drivers include the increasing prevalence of chronic pain and cough conditions, structured regulatory frameworks, and advancements in controlled-release formulations.

What are the major challenges facing the codeine sulfate market?

Major challenges include high production and commercialization costs, strict regulatory controls, and the prevalence of counterfeit products.

Which region is expected to grow the fastest in the codeine sulfate market?

The Asia Pacific region is expected to grow at the fastest CAGR of 5.5% during the forecast period.

Sources

1. Research and Markets - Codeine phosphate (CAS 52-28-8) Global Market Research Report
2. Drugs.com - Codeine Prices, Coupons, Copay Cards & Patient Assistance
3. Grand View Research - Opioids Market Size, Share & Growth Analysis Report, 2030
4. Research and Markets - Codeine Market Size, Competitors, Trends & Forecast to 2030
5. BC Provincial Academic Detailing Service - Opioids in Chronic Non-Cancer Pain: The Basics